Login / Signup

Liver injury caused by oral anticoagulants: A population-based retrospective cohort study.

Helgi K BjörnssonDavid O GudmundssonEinar Stefan Björnsson
Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Rivaroxaban was the only OAC associated with DILI during the 10-year study period. Approximately 1 in 1100 patients treated with rivaroxaban developed DILI. Other OACs were not associated with liver injury in this population-based study.
Keyphrases
  • drug induced
  • liver injury
  • atrial fibrillation
  • oral anticoagulants
  • venous thromboembolism
  • pulmonary embolism